Venous Thromboembolism While on Anticoagulation With Apixaban
| Autor: | Fuad Habash, Farah Mazahreh, Angel López-Candales |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class Cardiology Low molecular weight heparin 030204 cardiovascular system & hematology Treatment failure 03 medical and health sciences 0302 clinical medicine Internal medicine medicine cardiovascular diseases business.industry General Engineering Warfarin Conventional treatment venous thromboembolism (vte) Hematology Pathophysiology cardiovascular diseases / blood PULMONARY EMBOLUS saddle pulmonary embolism failed anticoagulation Apixaban business Venous thromboembolism 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| Popis: | Venous thromboembolism (VTE) is a common condition whose pathophysiology is explained by Virchow's triad with stasis, hypercoagulability, and endothelial injury. Direct oral anticoagulants (DOACs) showed non-inferiority when compared with conventional treatment using subcutaneous low molecular weight heparin (LMWH) and warfarin, but treatment failure is a concern and remains a challenge for physicians. In our case report, we present a patient who had VTE in the form of a saddle pulmonary embolus while on apixaban. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|